Cover Image

Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment

Show other versions (10)

In previous studies CD8+ T cells specific for melanocyte antigens have been frequently found in melanoma patients responding to interleukin-2 (IL-2)-based therapies. In our study we analyzed the suitability of using circulating T cells from melanoma patients with clinical response after IL-2-based t...

Full description

Saved in:
Bibliographic Details
Main Authors: Scheibenbogen, Carmen (Author) , Song, Mingxia (Author) , Schadendorf, Dirk (Author)
Format: Article (Journal)
Language:English
Published: 14 January 2002
In: International journal of cancer
Year: 2002, Volume: 98, Issue: 3, Pages: 409-414
ISSN:1097-0215
DOI:https://doi.org/10.1002/ijc.10205
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/https://doi.org/10.1002/ijc.10205
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.10205
Get full text
Author Notes:Carmen Scheibenbogen, Yuansheng Sun, Ulrich Keilholz, Mingxia Song, Stefan Stevanovic, Anne Marie Asemissen, Dirk Nagorsen, Eckhard Thiel, Hans-Georg Rammensee and Dirk Schadendorf
Search Result 3
Cover Image

Patterns of constitutive and IFN-γ inducible expression of HLA class II molecules in human melanoma cell lines by Rodríguez, Teresa (Author) , Méndez, Roman (Author) , Schadendorf, Dirk (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Search Result 4
Cover Image

Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes by Blöthner, Sandra (Author) , Hemminki, Kari (Author) , Chen, Bowang (Author) , Ugurel, Selma (Author) , Schadendorf, Dirk (Author) , Kumar, Rajiv (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Search Result 5
Cover Image

Dose-intensified bi-weekly temozolomide in patients with asymptomatic brain metastases from malignant melanoma: a phase II DeCOG/ADO study by Schadendorf, Dirk (Author) , Ugurel, Selma (Author) , Figl, Adina (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Search Result 6
Cover Image

In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatol... by Ugurel, Selma (Author) , Schadendorf, Dirk (Author) , Figl, Adina (Author) , Rittgen, Werner (Author) , Delorme, Stefan (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Search Result 7
Cover Image

Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma by Ugurel, Selma (Author) , Sucker, Antje (Author) , Rittgen, Werner (Author) , Schadendorf, Dirk (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Search Result 8
Cover Image

Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma by Fink, Wolfram (Author) , Figl, Adina (Author) , Figl, Robert (Author) , Ugurel, Selma (Author) , Schadendorf, Dirk (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Search Result 9
Cover Image

Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients by Ugurel, Selma (Author) , Schadendorf, Dirk (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Search Result 10
Cover Image

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon α, and interleukin 2 by Becker, Jürgen C. (Author) , Schadendorf, Dirk (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Show all versions (11)

Similar Items